Quinolones News

#1 October 16, 2009

Asian-Pacific Consensus Guidelines recommend levofloxacin for H. pylori infection

The second Asia-Pacific Consensus Conference has reviewed the latest information on Helicobacter pylori management. The current recommended first-line treatment is a PPI-based triple therapy involving clarithromycin and metronidazole. However, in parts of Asia there is increasing resistance to both these drugs and a number of recommended salvage therapies have been proposed. One of these is levofloxacin-based triple therapy. 

PMID: 19788600

J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600.

Source :

Return to Quinolones News Index


  ©1998- BIOMEDIS International, Ltd. All rights reserved. Reproduction in any manner in whole or part prohibited.